Dimed Distribuidora de Medicamentos

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

13 Mar 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

6.3%

-1.5%

6.3%

-1.5%

You can edit this narrative until May 12 6:03 AM. Then, changes will post as Updates.

Author's Valuation

R$11.915.5% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates7

Shared on 01 May 25

Fair value Increased 0.76%

Shared on 24 Apr 25

Fair value Decreased 4.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 2.75%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 0.67%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on 02 Apr 25

Fair value Decreased 7.97%

Shared on 26 Mar 25

Fair value Increased 4.36%

AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to -0.0%.

Shared on 19 Mar 25

Fair value Increased 4.12%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to 0.0%.

AnalystConsensusTarget Fair Value

R$11.9

15.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

11.80%

Food and Staples Retail revenue growth rate

0.18%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

20.19%

Calculation

R$209.36m

Earnings '28

13.95x

PE Ratio '28

R$2.92b

Market Cap '28

R$2.92b

Market Cap '28

142.41m

No. shares '28

R$20.51

Share Price '28

R$20.51 Share Price '28

Discounted to 2025 @ 19.74% p.a.

R$11.95

Fair Value '25